Daiwa SB Investments Ltd. Cuts Position in Xylem Inc (XYL)

Daiwa SB Investments Ltd. trimmed its position in Xylem Inc (NYSE:XYL) by 56.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,634 shares of the industrial products company’s stock after selling 13,720 shares during the period. Daiwa SB Investments Ltd.’s holdings in Xylem were worth $725,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in XYL. Invictus RG acquired a new stake in Xylem during the 3rd quarter worth about $104,000. Harfst & Associates Inc. grew its position in Xylem by 26.1% during the 2nd quarter. Harfst & Associates Inc. now owns 2,433 shares of the industrial products company’s stock worth $134,000 after purchasing an additional 503 shares during the period. Tower Research Capital LLC TRC acquired a new stake in Xylem during the 2nd quarter worth about $168,000. FNY Partners Fund LP grew its position in Xylem by 2,700.0% during the 3rd quarter. FNY Partners Fund LP now owns 2,800 shares of the industrial products company’s stock worth $175,000 after purchasing an additional 2,700 shares during the period. Finally, Federated Investors Inc. PA grew its position in Xylem by 5.8% during the 2nd quarter. Federated Investors Inc. PA now owns 3,286 shares of the industrial products company’s stock worth $182,000 after purchasing an additional 181 shares during the period. 85.04% of the stock is currently owned by hedge funds and other institutional investors.

In other news, insider Tomas Brannemo sold 2,260 shares of the firm’s stock in a transaction dated Tuesday, December 19th. The stock was sold at an average price of $67.75, for a total transaction of $153,115.00. Following the sale, the insider now directly owns 10,975 shares in the company, valued at approximately $743,556.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Steven R. Loranger sold 17,139 shares of the firm’s stock in a transaction dated Wednesday, December 20th. The shares were sold at an average price of $68.10, for a total value of $1,167,165.90. Following the sale, the director now owns 26,150 shares in the company, valued at $1,780,815. The disclosure for this sale can be found here. Insiders have sold a total of 150,777 shares of company stock worth $10,097,757 over the last 90 days. Insiders own 0.75% of the company’s stock.

Shares of Xylem Inc (NYSE XYL) opened at $70.46 on Friday. Xylem Inc has a 12-month low of $46.67 and a 12-month high of $70.79. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.26 and a current ratio of 1.76. The company has a market capitalization of $12,650.00, a PE ratio of 40.97, a PEG ratio of 1.65 and a beta of 1.18.

Xylem (NYSE:XYL) last posted its earnings results on Tuesday, October 31st. The industrial products company reported $0.65 EPS for the quarter, beating the Zacks’ consensus estimate of $0.64 by $0.01. Xylem had a return on equity of 17.74% and a net margin of 6.85%. The firm had revenue of $1.20 billion for the quarter, compared to analysts’ expectations of $1.18 billion. During the same period last year, the firm earned $0.54 EPS. The company’s quarterly revenue was up 33.2% on a year-over-year basis. analysts predict that Xylem Inc will post 2.39 earnings per share for the current fiscal year.

XYL has been the topic of several analyst reports. Seaport Global Securities reaffirmed a “buy” rating on shares of Xylem in a research report on Wednesday, November 1st. Zacks Investment Research raised Xylem from a “hold” rating to a “buy” rating and set a $71.00 price target on the stock in a research report on Thursday, October 5th. Cowen reaffirmed a “buy” rating and set a $70.00 price target on shares of Xylem in a research report on Thursday, September 21st. Oppenheimer reaffirmed a “buy” rating on shares of Xylem in a research report on Tuesday, October 31st. Finally, Boenning Scattergood reaffirmed a “buy” rating on shares of Xylem in a research report on Friday, December 15th. Seven analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $65.92.

TRADEMARK VIOLATION NOTICE: “Daiwa SB Investments Ltd. Cuts Position in Xylem Inc (XYL)” was originally reported by Week Herald and is the property of of Week Herald. If you are accessing this news story on another domain, it was copied illegally and republished in violation of United States & international copyright legislation. The original version of this news story can be viewed at https://weekherald.com/2018/01/13/daiwa-sb-investments-ltd-cuts-position-in-xylem-inc-xyl.html.

Xylem Company Profile

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply